Prevalence and correlates of illicit methylphenidate use among 8th, 10th, and 12th grade students in the United States, 2001

Journal of Adolescent Health

Volumn 35, Issue 6, 2004, Pages 501-504

  McCabe, Sean Esteban ^a   Teter, Christian J ^a   Boyd, Carol J ^a   Guthrie, Sally K ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

ADHD; Adolescence; Illicit use; Methylphenidate; Substance abuse

Indexed keywords

ILLICIT DRUG; METHYLPHENIDATE;

ADOLESCENT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG ABUSE; FEMALE; GEOGRAPHY; HUMAN; MALE; NORMAL HUMAN; PREVALENCE; PRIORITY JOURNAL; RACE;

EID: 9644303113     PISSN: 1054139X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1054-139X(04)00067-9     Document Type: Article

References (12)

1. Goldman L.S., Genel M., Bezman R.J., Slanetz P.J. Council on Scientific Affairs, American Medical Association. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. JAMA. 279:1998;1100-1107
2. Kollins S.H., MacDonald E.K., Rush C.R. Assessing the abuse potential of methylphenidate in nonhuman and human subjects A review. Pharmacol Biochem Behav. 68:2001;611-627
3. Johnston L.D., O'Malley P.M., Bachman J.G. Monitoring the Future National Survey Results on Drug Use, 1975-2001, Volume I Secondary School Students. 2002;National Institute on Drug Abuse, Bethesda, MD
4. Indiana Resource Prevention Center. ATOD use by Indiana children and adolescents. Available at: http://www.drugs.indiana.edu/drug_stats/youth2002/ stats2002.html. Accessed July 1, 2003
5. Klein-Schwartz W. Pediatric methylphenidate exposures 7-year experience of poison centers in the United States. Clin Pediatr. 42:2003;159-164
6. Foley R., Mrvos R., Krenzelok E.P. A profile of methylphenidate exposures. J Toxicol Clin Toxicol. 38:2000;625-630
7. Jessor R., Donovan J.E., Costa F.M. Beyond Adolescence Problem Behavior and Young Adult Development. 1991;Cambridge University Press, Cambridge, UK
8. Cox E.R., Motheral B.R., Henderson R.R., Mager D. Geographic variation in the prevalence of stimulant medication use among children 5 to 14 years old Results from a commercially insured US sample. Pediatrics. 111:2003;237-243
9. Lafever G.B., Dawson K.V., Morrow A.L. The extent of drug therapy for attention deficit-hyperactivity disorder among children in public schools. Am J Public Health. 89:1999;1359-1364
10. Safer D.J., Malever M. Stimulant treatment in Maryland public schools. Pediatrics. 106:2000;533-539
11. O'Malley P.M., Bachman J.G., Johnston L.D. Reliability and consistency in self-reports of drug use. Int J Addict. 18:1983;805-824
12. Johnston L.D., O'Malley P.M. Issues of validity and population coverage in student surveys of drug use. NIDA Res Monogr. 57:1985;31-54